Candel Therapeutics, Inc. (CADL)
NASDAQ·Healthcare·Biotechnology
$8.10
+1.63%
Mkt Cap $469.95M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+85.2%
Consensus $15.00 vs current $8.10
NASDAQ·Healthcare·Biotechnology
$8.10
+1.63%
Mkt Cap $469.95M
Buy
3
Hold
0
Sell
0
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
+85.2%
Consensus $15.00 vs current $8.10